WNT5A has been demonstrated to inhibit the cell growth, migration and invasiveness of thyroid and colorectal cancer cells [48, 49], while increased WNT5A expression is involved in the aggressiveness of other types of cancers, such as melanoma [50] and gastric cancer [51]. Here, WNT5A is linked to melanoma.